A standard database format for clinical trials of pain treatments: An ACTTION–CDISC initiative
Robert H. Dworkin(University of Rochester Medical Center), Hilary Wilson(University of Washington), Allison H. Lin(United States Food and Drug Administration), James Ottinger, Richard Malamut(Teva Pharmaceuticals (Czechia)), David St. Peter(Pacira (United States)), Bob A. Rappaport, Yun Lu(University of Alabama at Birmingham), David Hewitt(Glasgow Royal Infirmary), Vladimir Skljarevski(Eli Lilly (United States)), Paul J. Desjardins(Rutgers, The State University of New Jersey), Shyamalie Jayawardena(Pfizer (United States)), Denis Michel(Institut de Recherche en Santé, Environnement et Travail), Frank Pucino(National Institutes of Health Clinical Center), Paul M. Peloso(Genoscience Pharma (France)), Laurie B. Burke(Center for Drug Evaluation and Research), Susan Timinski(Teva Pharmaceuticals (United States)), Christine R. West(Pfizer (United States)), Mila Etropolski(Consumer Healthcare Products Association), Stephen Kopko(Clinical Research Consortium), Dennis C. Turk(University of Washington), Robert R. Allen(AstraZeneca (United States))
Cited by 6
Related Papers
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
|Psychological Bulletin|2007|3.3k
Basal cells as stem cells of the mouse trachea and human airway epithelium
|Proceedings of the National Academy of Sciences|2009|1.6k
Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
|Mayo Clinic Proceedings|2010|1.3k